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ABSTRACT 
Breast Cancer is the second foremost reason of Cancer mortality in females globally. The conventional treatments available for Breast Cancer 
include surgery yet they are related to serious side effects that have moved the worldwide focus towards Complementary and Alternative 
Medicines (CAM). One of the emerging strategies has been the use of plant extracts for synthesizing metal nanoparticles (such as gold and 
silver) for anticancer applications. The objective of this study is to reflect the current availed study on green synthesis of silver nanoparticles 
(AgNps) with its future prospects to treat Breast Cancer. The development of eco-friendly and reliable techniques for silver nanoparticles 
synthesis is a vital initiative in the area of nanotechnology. Brassica oleracea var. italica Plenck Leaves Extract (LE) prepared by maceration 
process and silver nanoparticles of LE prepared by using biological reduction method. Female rats were divided into 5 groups, Group-I served 
as Positive Control and received normal saline. Group-II served Negative Control (Tumor Bearing) and was treated with single dose of MCF 7. 
Breast Cancer Cells (1.7 mg/pellet). Group-III served Standard Control (Tumor Bearing) treated with Paclitaxel 40 mg/Kg. Group-IV served test 
and treated with LE 400 mg/Kg, Group-V served test and treated with LENP 400 mg/Kg respectively about 21 days and on 21th day blood 
samples were collected for Hematological Parameters and Feed and Water Consumption, Body Weight Determination and Organ Weight were 
estimated. These discoveries infer that the synthesized Silver nanoparticles utilizing green nanotechnology could be a perfect methodology to 
battle malignant growth and irresistible ailments. 
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1. INTRODUCTION 
Breast Cancer is the second most leading cause of cancer 
death in women worldwide, and is predictable to surpass 
heart diseases in the next few years [1]. It accounts for 
around 7% of global Cancer burden and one-fifth of all the 
Cancers in India [2]. As indicated by the American Cancer 
Society, a gauge of 29% occurrences and 15% deaths due to 
Breast Cancer around the world (Siegel et al., 2014) has been 
predicted. In India, Breast Cancer was the leading Cancer 
among females (24.85%) with the highest incidence and 
death rates being 10.53 and 16.18 %, respectively [3]. 
Herbal medicine that forms an integral part of CAM had 
reported to play an indicative part in the management of 
Breast Cancer [4]. Even though medicinal plants) and their 
bioactive have been reported to be highly potent anticancer 
agents, the widespread use of herbal bioactive has been 
restricted due to their hydrophobic nature that reduces their 
bioavailability and thusly diminishes their helpful adequacy 
[5]. This issue has been overcome with the advent of 
nanotechnology, which has had a significant effect on the 
advancement of Novel Drug Delivery Systems (NDDS) [6]. 
Lots of efforts have been undertaken to use Modern 
Nanotechnology to deliver herbal based drugs [7] for safer 
and more effective treatment of Breast Cancer. One of the 
emerging strategies has been the use of herbal extracts for 
synthesizing metal nanoparticles (such as gold and silver) 
for anticancer applications. Despite the fact that among the 
different biological methods for silver nanoparticle 
amalgamation, microorganism intervened combination isn't 
of industrial feasibility because of the prerequisites of 
exceedingly aseptic conditions and their support. Based on 
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the above background, the purpose of this study was to 
interrogate the capability of nanoparticles in delivery of 
herbals or their bioactive in Breast Cancer Cells. It involves 
synthesis, characterization and biological studies of 
nanoparticles conjugated with Brassica oleracea var. italica 
Plenck against Breast Cancer. 
2. MATERIALS AND METHODS 
2.1 Authentication of Plant 
The plant was recognized and validated from Botanical 
Survey of India, Western Regional Center, Pune, 
Maharashtra, India. 
2.2 Preparation of extract of Brassica oleracea var. 
italica Plenck leaves. 
1000 gm of Leaves of Brassica oleracea var. italica Plenck 
were cut in to the small pieces and allowed for maceration 
with solvent mixture having ethanol and water (6:4) ratio 
for 7 days. After maceration filtration was carried out. It is 
then allowed for evaporation of solvent. After evaporation, 
extract of Brassica oleracea var. italica Plenck leaves (LE) 
was weighed [8]. 
2.3 Biosynthesis of silver nanoparticles by using LE 
Silver Nitrate concentrations ranging from 1 mM, 2 mM and 
3 mM for silver nanoparticles synthesis were used and 1 ml, 
1.5 ml and 2 ml. LE concentrations were used in (5:1) 
concentrations. Prepared solution of Extract was placed 
drop wise in AgNO3 solution. Colour change was observed 
after time interval of 30 min, 60 min, 90 min, 120 mins, 150 
min, 180 min, 12 h, 24 h and 48 h as the arrangement 
diverted into dark colored from yellow arrangement at room 
temperature proposing development of silver nanoparticles. 
[9]. 
2.4 Experiment design for Anticancer Activity 
2.4.1 Animals 
Female Wistar Albino Rat (National Institute of Biosciences 
(NIB), Pune, India) weighing between 180 to 250 g was used. 
Housing of Experimental Animals under standard conditions 
of temperature, 12 h/12 h light/dark cycle and feed with 
standard pellet diet and tap water was done. The study 
protocol was placed before Institutional Animal Ethics 
Committee and approved vide letter number 
DYPIPSR/IAEC/17-18/P-20. 
All the experiments were approved and conducted as per the 
guidelines of local animal ethical committee. Acute oral 
toxicity was performed according to OECD-423 at dose 4000 
mg/kg. 
All female rats were divided into 5 groups each group 
contain 6 animals. 
Group-I served Positive Control and received normal saline.  
Group-II served Negative Control (Tumor Bearing) was 
treated with single dose of MCF 7 breast cancer cells (1.7 
mg/pellet).  
Group-III served as Standard Control (Tumor Bearing) 
treated with Paclitaxel 40 mg/Kg. 
Group-IV served as Test and treated with LE 400 mg/Kg. 
Group-V served as Test and treated with LENP 400 mg/Kg. 
2.4.2 Acute Toxicity Study in Wistar Albino Rat. 
Acute toxicity on oral administration of all samples at 
different doses of 300, 2000 and 4000 mg/kg was carried 
out. Sign of morbidity and mortality in animals during the 
period of experiment for acute toxicity was observed. 
2.4.3. Induction of Breast Cancer (Murine Tumour 
Model) 
Breasts were inoculated with estradiol-17β (1.7 mg/pellet) 
before an infusion of 1×107 MCF 7 breast malignant growth 
cells subcutaneously into inguinal locale of mammary fat 
cushion. The tumor size watched and estimated in three 
measurements with calipers each 2 days beginning at day 7. 
After confirmation of tumour induction by histopathology 
treatment was started. Standard and Test samples were 
injected in to Animals according to schedule [10]. 
2.5 Evaluation Parameters for Anticancer Activity 
2.5.1 Feed and Water consumption 
The measure of feed and water devoured for 24 h was 
estimated week by week from the amount of feed and water 
provided and the amount remaining after 24 h for till the 
end of the experiment. 
2.5.2 Body Weight Determination 
Body Weight of individual animal was noted week after 
week till end of the investigation. 
2.5.3 Hematological Parameters 
Blood of all experimental animals was collected by retro 
orbital method before cell line injection, after cell line 
injection and completion of treatment also, utilized for the 
assessment of red blood cell count (RBC), Hemoglobin (Hb) 
content and white blood cell count (WBC). Examination was 
made among all groups. Blood was immediately transferred 
into EDTA bulbs for hematological parameters examination. 
2.5.4 Organ Weight 
The organs under examination were extracted from the 
animal and weighed. The weights of the organs, such as, 
Lung, Liver, Kidney, Heart, Brain and Spleen were recorded 
and contemplated for any strange put on or loss of weight. 
This gives a primer affirmation with respect to the adverse 
effects (assuming any) of the medication under test. The 
weights of the organs expressed as relative loads as g/100 g 
b.w. and determined by following equation:   
Relative Organ Weight=  
                      
                                     
     
2.5.5 Statistical analysis 
All analyses were carried out in triplicate, freely, and the 
outcomes were communicated as the mean ± SD. Measurable 
examinations of the information were performed utilizing 
the Graph Pad Prism8 programming, variant 8.01. Results 
were communicated as mean ± SD of the demonstrated 
number of autonomous trials. Investigation of difference 
(ANOVA) was utilized to think about the mean estimation of 
information and P<0.05 were treated as significant. 
3. RESULTS AND DISCUSSION 
3.1 Identification and authentication: 
The plant was identified and authenticated as Brassica 
oleracea var. italica Plenck (Family: Brassicaceae) from 
Botanical Survey of India, Western Regional Centre, Pune 
(BSI), Maharashtra, India. (Voucher specimen No. RBC-3, 
BSI /WRC /IDEN.CER /2016/667). 
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3.2 Visual Observation 
Visual perception of colour change from yellow to dark 
brown after addition of extract to AgNO3 was observed 
demonstrating the biosynthesis of AgNps by diminishing Ag+ 
particles with the concentrate as topping operators as 
shown in Figure 1. 
 
 
 
Figure 1: Confirmation of Formation of Brassica oleracea var. italica Plenck Leaves Extract Loaded AgNps. 
 
3.3 Acute Toxicity 
Test samples were subjected to acute toxic effect as per the 
guideline 423 of OECD, wherein 4000 mg/kg was used as the 
limit test dose. Toxic symptom or mortality related to 
treatment were not observed after test sample 
administration by oral route at 300, 2000 and 4000 mg/kg 
dose. 
3.4 Murine Tumour Model 
Murine tumor model was chosen to decide the anticancer 
potential of extracts and formulations. After the cell line 
treatment Confirmation of tumour formation was done by 
Histopathology. Studies noted multifocal mild 
neutrophilic/lymphocytic infiltration and multifocal mild 
neovasularization at dermis and subcutis remarked as Mild 
inflammation with neovascularization. Large tracts of tumor 
cells with little stroma with fibrous tissue at subcutis was 
observed. Diffuse nuclear pleomorphism without 
demonstration of gland formation was noted (variations in 
nuclear size and staining), Increased nuclear cytoplasm ratio 
with eosinophilic cytoplasm is seen. Mitotic figures are 
observed (1-2/3 hpf) Multifocal moderate lymphocytic 
infiltration at tumor area (2+) Multifocal moderate 
neovasularization (3+) indicated Low grade Solid Mammary 
Adenocarcinoma. 
Diffusely severe tract of neoplastic cells spread across 
complete subcutaneous area with diffuse moderate stroma 
along with fibrous tissue is observed in negative control 
group experimental animal. Moderate cellular 
pleomorphism with round to oval nucleus and pink 
cytoplasm, moderate anaplasia and increased mitotic is also 
noted. Focal mild necrosis and diffuse moderate 
inflammation at tumor site with neovasularization is seen in 
positive control animal. 
When compared with experimental animal of negative 
control group, experimental animal of Standard drug, LE and 
LENP treated Female Rats revealed reduced size, 
distribution and severity of tumor area. Further, increased 
necrosis at tumor site of treated Female Rat suggests 
mitigatory effect. It has been noted that experimental animal 
treated with nanoparticles revealed higher efficacy than 
extracts. 
3.5 Effect on Treated Animals 
3.5.1 Feed and Water Consumption 
The amount of feed and water consumed for 24 hours was 
estimated week by week from the amount of feed and water 
provided and the amount remaining after 24 h till the end of 
experiment. 
After administration of investigating compounds, the study 
period significantly affected the feed intake. After Injection 
of Cell line Negative Control Group had the lowest feed 
intake as compare to the Normal Control Group. Followed by 
Test Group (LE, LENP) the food intake of rats significantly 
increases as compared to Negative Control Group as 
demonstrated in Table 1. 
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Table 1: Feed Consumption 
Group Before Cell line Injection  At the time of Cell line Injection  After Treatment 
PC 47.5 ± 4.58 48.6 ± 6.45 47.3 ± 4.58** 
NC 50.5 ± 7.54 27.3 ± 4.78 25.3 ± 7.59*** 
STD 55 ± 4.56 36.5 ± 5.48 45.3 ± 6.45*** 
LE 53.6 ± 4.89 31 ± 6.89 38 ± 4.96** 
LENP 46 ± 4.99 34 ± 6.41 41.2 ± 3.96** 
 
All the values are expressed as mean ± SD (n=6); Vs Normal Control; *p<0.05, **p<0.01, ***p<0.001 Vs Negative Control. 
Whereas, PC: Positive Control, NC: Negative Control, STD: Standard Control LE: Leaves Extract (Test Sample), LENP: Leaves 
Extract mediated AgNps (Test Sample). 
 
3.5.2 Water Consumption 
After administration of cell line, the water intake of negative 
control group significantly decreases as compared to Normal 
Control Group. However, in test and standard compound 
treated group the water intake capacity of rats significantly 
increase compared to Negative Control Group as shown in 
Table 2. 
 
Table 2: Water Consumption 
Group 
Before Cell line Injection  At the time of Cell line Injection  After Treatment 
PC 189 ± 1.23** 189.5 ± 2.12 185.14 ± 2.89** 
NC 187 ± 1.56*** 124.5 ± 2.65 115 ± 2.98*** 
STD 190 ± 2.01* 147 ± 3.14 168 ± 3.44** 
LE 185 ± 2.66** 134.5 ± 2.44 144.6 ± 3.11** 
LENP 184 ± 3.66*** 128.5 ± 1.89 160 ± 2.87*** 
All the values indicated as mean ± SD (n=6); Vs Normal Control; *p<0.05, **p<0.01, ***p<0.001 Vs Negative Control. Whereas, 
PC: Positive Control, NC: Negative Control, STD: Standard Control LE: Leaves Extract (Test Sample), LENP: Leaves Extract 
mediated AgNps (Test Sample). 
3.5.3  Body Weight Determination 
The body weight is a parameter considered as an indicator 
of symptoms in different organs. Table 3 demonstrates the 
weights of rats after administration of investigating 
compound. The data shows convincing differences between 
Positive Control and Negative Control Group. The Negative 
Control Group had significantly increased body weight in 
comparison to Positive Control Group. However, towards the 
end of the experiment, slight differences in weights were 
seen in all the test and standard groups contrasted with 
control as shown in Table 3. 
 
Table 3: Body Weight Determination 
Group Before Cell line Injection  At the time of Cell line Injection  After Treatment 
PC 171.25 ± 2.05** 180.75 ± 1.54 182 ± 5.65*** 
NC 181.25 ± 3.60*** 196.75 ± 2.69 200 ± 1.58* 
STD 138.5 ± 4.02* 154.25 ± 7.21 170.2 ± 3.62** 
LE  151.25 ± 4.54** 172 ± 3.65 176.75 ± 1.32** 
LENP 139.75 ± 2.44*** 157 ± 2.78 162 ± 2.78*** 
 
All the values are expressed as mean ± SD (n=6); Vs Normal Control; *p<0.05, **p<0.01, ***p<0.001 Vs Negative Control. 
Whereas, PC: Positive Control, NC: Negative Control, STD: Standard Control LE: Leaves Extract (Test Sample), LENP: Leaves 
Extract mediated AgNps (Test Sample). 
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3.5.4 Organ Weight 
Organ Weight can be the most delicate marker to know the 
impact of an experimental task and made a decision by 
significant differences in Organ Weight among treated and 
untreated animals Liver, Kidney Lungs, Heart, Spleen and 
Brain have been used to evaluate safety of test drugs as 
shown in Table 4. 
 
Table 4: Organ Weight 
AVG.WT(gm
) /GROUP 
LIVER KIDNEY each LUNGS HEART SPLEEN BRAIN 
PC 5 ± 0.11* 0.5 ± 0.01 2 ± 01 0.5 ± 0.01 1.5 ± 0.16 1.5 ± 0.12 
NC 13.5 ± 2.55* 0.5 ± 0.02 2 ± 04 0.5 ±0.03 1.4 ± 0.23 1.4 ± 0.54 
STD 6.2 ± 1.22** 0.5 ± 0.01 2.1 ± 03      0.5 ± 0.05 1.5 ± 0.24 1.5 ± 0.42 
LE 7.6 ± 3.11* 0.5 ± 0.03 2.4 ± 0.5 0.5 ± 0.04 1.4 ± 0.54 1.5 ±0.54 
LENP 
6.8 ± 1.66 ± 
2.1* 
0.5 ± 0.11 2.3 ±0.7 0.5 ± 0.02 1.5 ± 0.78 1.4 ± 0.78 
 All the values are revealed as mean ± SD (n=6); Vs Normal control; *p<0.05, **p<0.01, ***p<0.001 Vs Negative control. 
Whereas, PC: Positive Control, NC: Negative Control, STD: Standard Control LE: Leaves Extract (Test Sample), LENP: Leaves 
Extract mediated AgNps (Test Sample). 
 
3.5.5 Hematological Parameters 
Furthermore, hematological indices in animals are critical to 
decide the toxicity risk since the variation in the blood 
system has greater prescient value in regard of human 
toxicity. Statistics in Table 5 show the concentration of RBC, 
Hb content, WBC, MCV, PCV, MCH, platelets count, MCHC, 
lymphocytes and neutrophils of all groups. These 
hematological parameters were significantly lower in 
Negative Control Group. While in test compounds and 
standard drug significantly increases as compared to 
Negative Control Group as demonstrated in Table 5. 
 
Table 5: Hematological Parameters 
Parameter Positive  Control Negative  Control Std LE LENP 
WBC (X103/µL) 4.87 ± 1.23 17.2 ± 1.01** 12.1 ± 2.31** 13.0 ± 1.11* 9.1 ± 0.66** 
RBC (X106/µL) 12.3 ± 1.59 6.2 ± 2.01* 8.55 ± 1.26* 7.18 ± 2.12** 8.91 ± 2.11** 
Hgb (g/dL) 15.7 ±  1.96 6.6 ± 1.23*** 7.9 ± 2.55* 8.5 ± 1.09*** 8.4 ± 1.22* 
MCV (fl) 56.2 ± 2.14 41.3 ± 4.56** 50.5 ± 1.45** 53.6 ± 2.36** 53.8 ± 2.11** 
MCH (pg) 20.5 ± 5.12 11.2 ± 2.45* 15.6 ± 2.11* 14.8 ± 1.12** 13.5 ± 2.32* 
MCHC (g/dL) 35.5 ± 3.36 33.3 ± 3.21** 35.4 ± 1.44** 35.2 ± 1.89* 34.4 ± 
1.96*** 
PLT (X103/µL) 663 ± 4.52 917 ± 2.15** 758 ± 5.55* 805 ± 4.12** 760 ± 4.55* 
Neutrophil (%) 24 ± 2.12 41 ± 1.23* 33 ± 2.55** 36 ± 2.16* 31 ± 2.11** 
Lymphocyte (%) 73 ± 1.25 109 ± 1.47*** 80 ± 3.12** 89 ± 2.10** 82 ± 1.22** 
Monocyte (%) 0.2 ± 1.35 3 ± 1.13* 1 ± 0.01* 3 ±  1.11** 1 ± 0.25** 
Eosinophil (%) 0.4 ± 0.12 1 ± 1.54** 1 ± 0.19* 2 ±   0.63*  2 ± 0.12* 
Basophil (%) 0 ± 0.00 0 ± 0.00ns 0 ± 0.00 0 ± 0.00 0 ± 0.00 
 
All the values are expressed as mean ± SD (n=6); Vs Normal Control; *p<0.05, **p<0.01, ***p<0.001 Vs Negative Control. 
Whereas, PC: Positive Control, NC: Negative Control, STD: Standard Control LE: Leaves Extract (Test Sample), LENP: Leaves 
Extract mediated AgNps (Test Sample). 
 
 
Chintamani et al                                                                                                 Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):472-477 
ISSN: 2250-1177                                                                                   [477]                                                                                     CODEN (USA): JDDTAO 
4. CONCLUSION 
Silver Nanoparticles (AgNps) were prepared by biological 
reduction method using Brassica oleracea var. italica Plenck 
Leaves extract. Synthesis of AgNps by biological reduction 
method is a sort of base up methodology wherein reduction 
is the fundamental reaction which was taken place. The 
decrease of silver particles prompts the development of 
stable silver nanoparticles. This work aimed to synthesis of a 
novel drug delivery system with herbal drug Brassica 
oleracea var. italica Plenck in order to reduce possible side 
effects of conventional treatment. In-Vivo studies suggest 
that Brassica oleracea var. italica Plenck Leaves extract 
mediated Silver Nanoparticles exhibit anticancer activity. 
These discoveries infer that the synthesized nanoparticles 
utilizing green nanotechnology could be a perfect procedure 
to battle malignant growth and irresistible illnesses. 
ACKNOWLEDGEMENT 
Author would like to acknowledge and thank to National 
Centre for Cell Science, Pune, Maharsahtra, India for 
providing Breast Cancer Cell lines and Botanical Survey of 
India, Pune for Authentication of Plant. Author also extend 
vote of thanks towards Amrutvahini College of Pharmacy 
Sangamner, Maharsahtra, India and Department of 
Biotechnology, Deogiri College, Aurangabad, Maharsahtra, 
India for providing infrastructural facility. 
REFERENCES 
1. Arora N, Talhouk A, McAlpine JN, Law MR, Hanley GE. Causes 
of death among women with epithelial ovarian cancer by 
length of survival post-diagnosis: a population-based study in 
British Columbia, Canada. International Journal of Gynecologic 
Cancer. 2019 Mar 1; 29(3):593-8. 
2. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, 
Piñeros M, Znaor A, Bray F. Estimating the global cancer 
incidence and mortality in 2018: GLOBOCAN sources and 
methods. International journal of cancer. 2019 Apr 
15;144(8):1941-53. 
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 
Global cancer statistics. CA: a cancer journal for clinicians. 
2011 Mar; 61(2):69-90. 
4. Klafke N, Mahler C, von Hagens C, Blaser G, Bentner M, Joos S. 
Developing and implementing a complex Complementary and 
Alternative (CAM) nursing intervention for breast and 
gynecologic cancer patients undergoing chemotherapy—
report from the CONGO (complementary nursing in 
gynecologic oncology) study. Supportive Care in Cancer. 2016 
May 1; 24(5):2341-50. 
5. Olivares-Vicente M, Barrajon-Catalan E, Herranz-Lopez M, 
Segura-Carretero A, Joven J, Encinar JA, Micol V. Plant-derived 
polyphenols in human health: biological activity, metabolites 
and putative molecular targets. Current drug metabolism. 
2018 Apr 1; 19(4):351-69. 
6. Kim CS, Mout R, Zhao Y, Yeh YC, Tang R, Jeong Y, Duncan B, 
Hardy JA, Rotello VM. Co-delivery of protein and small 
molecule therapeutics using nanoparticle-stabilized 
nanocapsules. Bioconjugate chemistry. 2015 Apr 30; 
26(5):950-4. 
7. Alexander A, Patel RJ, Saraf S, Saraf S. Recent expansion of 
pharmaceutical nanotechnologies and targeting strategies in 
the field of phytopharmaceuticals for the delivery of herbal 
extracts and bioactives. Journal of Controlled Release. 2016 
Nov 10; 241:110-24. 
8. Bhavani R, Kotteeswaran R, Rajeshkumar S. Hepatoprotective 
effect of Brassica oleracea vegetable and its leaves in 
Paracetamol induced liver damage in albino rats. Int. J. 
ChemTech Res. 2014; 6(7):3705-12. 
9. Kumar V, Yadav SC, Yadav SK. Syzygium cumini leaf and seed 
extract mediated biosynthesis of silver nanoparticles and 
their characterization. Journal of Chemical Technology & 
Biotechnology. 2010 Oct; 85(10):1301-9. 
10. Zhang Y, Zhang GL, Sun X, Cao KX, Ma C, Nan N, Yang GW, Yu 
MW, Wang XM. Establishment of a murine breast tumor 
model by subcutaneous or orthotopic implantation. Oncology 
letters. 2018 May 1; 15(5):6233-40. 
 
